BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 32710174)

  • 1. A prospective nutritional assessment using Mini Nutritional Assessment-short form among patients with head and neck cancer receiving concurrent chemoradiotherapy.
    Hung CY; Hsueh SW; Lu CH; Chang PH; Chen PT; Yeh KY; Wang HM; Tsang NM; Huang PW; Hung YS; Chen SC; Chou WC
    Support Care Cancer; 2021 Mar; 29(3):1509-1518. PubMed ID: 32710174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the MNA-SF, MUST, and NRS-2002 nutritional tools in predicting treatment incompletion of concurrent chemoradiotherapy in patients with head and neck cancer.
    Hsueh SW; Lai CC; Hung CY; Lin YC; Lu CH; Yeh KY; Tsang NM; Hung YS; Chang PH; Chou WC
    Support Care Cancer; 2021 Sep; 29(9):5455-5462. PubMed ID: 33704566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of early nutrition counseling in head and neck cancer patients with normal nutritional status.
    Ho YW; Yeh KY; Hsueh SW; Hung CY; Lu CH; Tsang NM; Wang HM; Hung YS; Chou WC
    Support Care Cancer; 2021 May; 29(5):2777-2785. PubMed ID: 32995998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Significance of Vulnerability Assessment in Patients with Primary Head and Neck Cancer Undergoing Definitive Concurrent Chemoradiation Therapy.
    Chou WC; Chang PH; Chen PT; Wang HM; Yeh KY; Lu CH; Hung YS; Tung-Chieh Chang J; Tsang NM; Ho YW; Chen SY; Lee SH; Hung CY; Wang LJ; Liao KC; Lin CH; Tang WR; Lin YC
    Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):602-611. PubMed ID: 31987971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of the pretreatment geriatric nutritional risk index for predicting severe adverse events in patients with head and neck cancer treated with chemoradiotherapy.
    Nakayama M; Ohnishi K; Adachi M; Ii R; Matsumoto S; Nakamura M; Miyamoto H; Hirose Y; Nishimura B; Tanaka S; Wada T; Tabuchi K
    Auris Nasus Larynx; 2022 Apr; 49(2):279-285. PubMed ID: 34509306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nutritional surveillance in head and neck cancer patients during radiotherapy--the difference between concurrent chemoradiotherapy using high-dose cisplatin and radiotherapy alone].
    Nakahara S; Yoshino K; Fujii T; Uemura H; Suzuki M; Nishiyama K; Inohara H
    Nihon Jibiinkoka Gakkai Kaiho; 2012 Oct; 115(10):902-9. PubMed ID: 23214048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic differences of the Mini Nutritional Assessment short form and long form in relation to 1-year functional decline and mortality in community-dwelling older adults receiving home care.
    Kiesswetter E; Pohlhausen S; Uhlig K; Diekmann R; Lesser S; Uter W; Heseker H; Stehle P; Sieber CC; Volkert D
    J Am Geriatr Soc; 2014 Mar; 62(3):512-7. PubMed ID: 24611678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing the adequacy of the MNA-SF, NRS-2002 and MUST nutritional tools in assessing malnutrition in hip fracture operated elderly patients.
    Koren-Hakim T; Weiss A; Hershkovitz A; Otzrateni I; Anbar R; Gross Nevo RF; Schlesinger A; Frishman S; Salai M; Beloosesky Y
    Clin Nutr; 2016 Oct; 35(5):1053-8. PubMed ID: 26231340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validity of the Self- Mini Nutritional Assessment (Self- MNA) for the Evaluation of Nutritional Risk. A Cross- Sectional Study Conducted in General Practice.
    Donini LM; Marrocco W; Marocco C; Lenzi A
    J Nutr Health Aging; 2018; 22(1):44-52. PubMed ID: 29300421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Objective evaluation of nutritional status using the prognostic nutritional index during and after chemoradiotherapy in Japanese patients with head and neck cancer: a retrospective study.
    Fujiwara D; Tsubaki M; Takeda T; Miura M; Nishida S; Sakaguchi K
    Eur J Hosp Pharm; 2021 Sep; 28(5):266-270. PubMed ID: 34426479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can the Mini Nutritional Assessment (MNA) Be Used as a Nutrition Evaluation Tool for Subacute Inpatients over an Average Length of Stay?
    McDougall KE; Cooper PL; Stewart AJ; Huggins CE
    J Nutr Health Aging; 2015 Dec; 19(10):1032-6. PubMed ID: 26624216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of two nutrition assessment tools in surgical elderly inpatients in Northern China.
    Zhou J; Wang M; Wang H; Chi Q
    Nutr J; 2015 Jul; 14():68. PubMed ID: 26170020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Geriatric Nutritional Risk Index as a prognostic factor in older adult patients with locally advanced head and neck cancer receiving definitive chemoradiotherapy with tri-weekly cisplatin.
    Fujiwara Y; Sato Y; Hayashi N; Fukuda N; Wang X; Nakano K; Ohmoto A; Urasaki T; Ono M; Tomomatsu J; Toshiyasu T; Mitani H; Takahashi S
    J Geriatr Oncol; 2023 Jun; 14(5):101523. PubMed ID: 37229881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-therapeutic nutritional assessment for predicting severe adverse events in patients with head and neck cancer treated by radiotherapy.
    Kono T; Sakamoto K; Shinden S; Ogawa K
    Clin Nutr; 2017 Dec; 36(6):1681-1685. PubMed ID: 27847115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early nutritional intervention improves treatment tolerance and outcomes in head and neck cancer patients undergoing concurrent chemoradiotherapy.
    Paccagnella A; Morello M; Da Mosto MC; Baruffi C; Marcon ML; Gava A; Baggio V; Lamon S; Babare R; Rosti G; Giometto M; Boscolo-Rizzo P; Kiwanuka E; Tessarin M; Caregaro L; Marchiori C
    Support Care Cancer; 2010 Jul; 18(7):837-45. PubMed ID: 19727846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential Utility of the Mallampati Score for Prediction of Treatment Compliance and Safety Profiles of Patients With Head and Neck Cancer Undergoing Definitive Concurrent Chemoradiotherapy.
    Su PH; Hsu CC; Hsueh SW; Hung CY; Yeh KY; Wang HM; Lu CH; Lin YC; Chang JT; Chou WC
    Anticancer Res; 2022 Nov; 42(11):5609-5618. PubMed ID: 36288852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute phase nutritional screening tool associated with functional outcomes of hip fracture patients: A longitudinal study to compare MNA-SF, MUST, NRS-2002 and GNRI.
    Inoue T; Misu S; Tanaka T; Kakehi T; Ono R
    Clin Nutr; 2019 Feb; 38(1):220-226. PubMed ID: 29456030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive Value of Albumin and Neutrophil-to-Lymphocyte Ratio Score for Treatment Completeness and Safety Profiles in Patients With Head and Neck Cancer Receiving Definitive Concurrent Chemoradiotherapy.
    Hsu CC; Chou WC; Hung YS; Lin SY; Hung CY; Yeh KY; Wang HM; Lu CH
    In Vivo; 2022; 36(6):2875-2883. PubMed ID: 36309354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutrition impact symptoms and associated outcomes in post-chemoradiotherapy head and neck cancer survivors: a systematic review.
    Crowder SL; Douglas KG; Yanina Pepino M; Sarma KP; Arthur AE
    J Cancer Surviv; 2018 Aug; 12(4):479-494. PubMed ID: 29556926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of Prophylactic Percutaneous Gastrostomy in Patients With Head and Neck Cancer Receiving Concurrent Chemoradiotherapy: A Multicenter Analysis.
    Neves MT; Ferreira A; Branco V; Abreu M; Alves FR; Baptista C; Graça J; Ferreira F; Malheiro M; Martins A
    Cureus; 2023 Sep; 15(9):e44637. PubMed ID: 37671078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.